 Adamis Pharmaceuticals has a strong list of potential catalysts that may have a positive impact on the share price. The recent sell-off has provided me an opportunity to accumulate. Adamis has a history of botched opportunities, however, the companys efforts continue to find ways to rally share price around catalysts. 